Heart Failure as a Risk Factor for Diabetes and Prediabetes Patients

Diabetes or prediabetes may put a patient at higher risk of developing heart failure / cardiovascular diseases. 

Racial and regional variations have been identified in the continuity of diabetes in patients who have reduced ejection fraction accompanied by heart failure (HFrEF). There has also been the identification of geographic distinctions in how diabetes can be managed among these patients. Patients with reduced ejection fraction accompanied by heart failure also show prediabetic dysglycemia infection, also known as prediabetes. Prediabetes has been associated with terrible outcomes as compared to normoglycemia. This paper dwells on how prediabetes is common in patients with HFrEF and the characteristics that these patients hold regarding diabetes and prediabetes. There is also an in-depth focus on the type of treatment, the high number of patients that are usually reported to have the disease, and the extent to which various individuals die at a given time. Previous studies suggest that diabetes and prediabetes are hazardous diseases in that they can kill an individual slowly. Approximately 1 out of 10 individuals in a given area suffer from diabetes or prediabetes. 

The study aimed to determine the effect of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction on patients with diabetes. In a particular group of patients from PARAGON-HF, several health measurements were taken, including body mass index, structural enrolment of the heart disease, and blood pressure, including systolic and diastolic blood pressure. Another health measurement that was taken was the rate of glomerulus filtration. There was a random assignment to the treatment of various patients using valsartan. Enrollment occurred between 7 and 8 years ago. Patients offered written consent to allow the process of enrollment to occur. The patients recorded a varying diagnosis of diabetes. Glycated hemoglobin was also another important measure for the patients. International Diabetes Expert committee grouped the patients into three groups based on their history of diabetic infection. Regular patients who indicated a usual health condition were less than 6%, while those implied prediabetic conditions were between 6% and 6.4%. Above 6.5% were patients who recorded a diabetic disease. Several cases arose of some patients dying due to kidney failure. Nonetheless, some patients improved their condition and therefore surpassed the state. Baseline characteristics depended on measures of standard variation, including mean, mode, and median.  

Approximately 2300 patients were found to have a diabetic infection. In total, there were about 4700 patients who were diagnosed. The number of patients who had diabetes constituted about 49%. Out of the 2300 patients, approximately 2060 patients had an informed diagnosis, while the rest were not informed before the diagnosis. Therefore, 7% of the patients had undiagnosed diabetes, while about 12% had diagnosed diabetes. The number of prediabetes patients was about 874, which accounted for about 6% of the total number of patients. Only about 1500 patients recorded a normal condition. This accounted for less than 6% of the total number of patients. More patients with diabetes were young, and most of them were male rather than female. Patients with diabetes registered a high body mass index. Such patients had already contracted high blood pressure and atherothrombotic disease initially. Other common conditions usually associated with diabetes include anemia and sleeping sickness. Patients with diabetes usually showed more significant breathing difficulties than prediabetes patients. The patients who registered normal health conditions did not have any difficulty breathing. However, studies indicated that such patients could also be susceptible to diabetes. 

The study focused on patients with diabetes, and sampling focused on specific patients rather than random selection. Therefore, the selected participants are only a tiny reflection of patients with HFpEF and HFrEF. Generally, diabetes and prediabetes have a significant impact on HFpEF. Patients with diabetes and prediabetes have a worse clinical status and a high risk of developing cardiovascular diseases. Glucose lowering is essential in reducing the effects of diabetes and prediabetes on various patients. 

Practice Pearls: 

• Patients with diabetes mellitus have a higher risk of developing heart failure. In addition, current evidence shows many molecular and biochemical changes characterized by diabetes and heart failure. 
• The conditions that are usually associated with heart failure include breathing difficulty. 
• Heart failure can also result in inflammations leading to hypertension. In addition, high blood pressure can damage the blood cells as the pressure continues.   

Jackson AM, Rørth R, Liu J, et al. Diabetes and prediabetes in patients with heart failure and preserved ejection fraction [published online ahead of print, 2021 Dec 17]. Eur J Heart Fail. 2021;10.1002/ejhf.2403. doi:10.1002/ejhf.2403 

Njideka Aginam, PharmD Candidate, South College School of Pharmacy 

See more about heart failure and diabetes.